Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kolb

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
The Journal of Biological Chemistry|December 24, 2016
PrenDB, a Substrate Prediction Database to Enable Biocatalytic Use of PrenyltransferasesJakub Gunera, Florian Kindinger, Shu-Ming Li, et al.
STAR Protocols|December 30, 2020
Micropatterning of Cells on Gold Surfaces for Biophysical ApplicationsCarolin Grandy, Peter Kolb, Fabian Port, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Similarity- and Substructure-Based Development of β<sub>2</sub>-Adrenergic Receptor Ligands Based on Unusual ScaffoldsDenis Schmidt, Jakub Gunera, Jillian G Baker, et al.
Life (Basel, Switzerland)|August 6, 2021
<i>In Vitro</i> Measurements of Cellular Forces and their Importance in the Lung-From the Sub- to the Multicellular ScalePeter Kolb, Annika Schundner, Manfred Frick, et al.
Drug Discovery Today|January 29, 2016
Drugging specific conformational states of GPCRs: challenges and opportunities for computational chemistryMaria Martí-Solano, Denis Schmidt, Peter Kolb, et al.
Pharmacology & Therapeutics|July 21, 2022
Allosteric modulation of GPCRs: From structural insights to in silico drug discoveryMargherita Persechino, Janik Björn Hedderich, Peter Kolb, et al.
Proteins|April 4, 2008
Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitorsPeter Kolb, Catherine Berset Kipouros, Danzhi Huang, et al.
Molecular Pharmacology|October 19, 2019
Comparative Docking to Distinct G Protein-Coupled Receptor Conformations Exclusively Yields Ligands with Agonist EfficacyMagdalena M Scharf, Moritz Bünemann, Jillian G Baker, et al.
Protein Science : a Publication of the Protein Society|September 18, 2008
A double-headed cathepsin B inhibitor devoid of warheadPatricia Schenker, Pietro Alfarano, Peter Kolb, et al.
Nature|December 24, 2014
Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexantJie Yin, Juan Carlos Mobarec, Peter Kolb, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|December 24, 2016
PrenDB, a Substrate Prediction Database to Enable Biocatalytic Use of PrenyltransferasesJakub Gunera, Florian Kindinger, Shu-Ming Li, et al.
STAR Protocols|December 30, 2020
Micropatterning of Cells on Gold Surfaces for Biophysical ApplicationsCarolin Grandy, Peter Kolb, Fabian Port, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Similarity- and Substructure-Based Development of β<sub>2</sub>-Adrenergic Receptor Ligands Based on Unusual ScaffoldsDenis Schmidt, Jakub Gunera, Jillian G Baker, et al.
Life (Basel, Switzerland)|August 6, 2021
<i>In Vitro</i> Measurements of Cellular Forces and their Importance in the Lung-From the Sub- to the Multicellular ScalePeter Kolb, Annika Schundner, Manfred Frick, et al.
Drug Discovery Today|January 29, 2016
Drugging specific conformational states of GPCRs: challenges and opportunities for computational chemistryMaria Martí-Solano, Denis Schmidt, Peter Kolb, et al.
Pharmacology & Therapeutics|July 21, 2022
Allosteric modulation of GPCRs: From structural insights to in silico drug discoveryMargherita Persechino, Janik Björn Hedderich, Peter Kolb, et al.
Proteins|April 4, 2008
Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitorsPeter Kolb, Catherine Berset Kipouros, Danzhi Huang, et al.
Molecular Pharmacology|October 19, 2019
Comparative Docking to Distinct G Protein-Coupled Receptor Conformations Exclusively Yields Ligands with Agonist EfficacyMagdalena M Scharf, Moritz Bünemann, Jillian G Baker, et al.
Protein Science : a Publication of the Protein Society|September 18, 2008
A double-headed cathepsin B inhibitor devoid of warheadPatricia Schenker, Pietro Alfarano, Peter Kolb, et al.
Nature|December 24, 2014
Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexantJie Yin, Juan Carlos Mobarec, Peter Kolb, et al.
Pageof 10